Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.08 | N/A |
| PEG Ratio (TTM) | 0.52 | N/A |
| P/S Ratio (TTM) | 1.21 | N/A |
| P/B Ratio (TTM) | 1.98 | N/A |
| P/FCF Ratio (TTM) | 6.01 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.96 | N/A |
| Price to 5YR AVG FCF Ratio | 8.06 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.38% | N/A |
| ROE (TTM) | 17.73% | N/A |
| Net Profit Margin (TTM) | 10.02% | N/A |
| ROIC 5YR AVG | 30.60% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 89.60% | 16.69% | 8.01% |
| Revenue | 2.87% | 4.81% | 6.50% |
| Net Income | 88.76% | 14.19% | 5.08% |
| Cash Flow | 21.12% | 18.55% | 12.33% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.29 | N/A |
| Interest Coverage (TTM) | 5.64 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.41 | N/A |
| LTL to 5YR AVG FCF | 1.17 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.99% | N/A |